Predictive Technology Group, Inc. (PRED)
Stock Price:
$0.2100 USD
-0.0200 (-8.70%)
Updated Oct 23, 2020 3:58 PM EDT - Market closed
Key Info
| Market Cap |
62.92M |
| Revenue (ttm) |
24.44M |
| Net Income (ttm) |
-85.90M |
| Shares Out |
299.60M |
| EPS (ttm) |
-0.30 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 23, 2020 |
| Last Price |
$0.2100 |
| Previous Close |
$0.2300 |
| Change ($) |
-0.0200 |
| Change (%) |
-8.70% |
| Day's Open |
0.2425 |
| Day's Range |
0.2100 - 0.2425 |
| Day's Volume |
5,303 |
| 52-Week Range |
0.1 - 1.81 |
More Stats
| Market Cap |
62.92M |
| Enterprise Value |
70.42M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
299.60M |
| Float |
246.58M |
| EPS (basic) |
-0.30 |
| EPS (diluted) |
-0.30 |
| FCF / Share |
-0.05 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
n/a |
| Short Ratio |
n/a |
| Short % of Float |
n/a |
| Beta |
-0.54 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
2.57 |
| PB Ratio |
1.25 |
| Revenue |
24.44M |
| Operating Income |
-56.70M |
| Net Income |
-85.90M |
| Free Cash Flow |
-14.09M |
| Net Cash |
-7.51M |
| Net Cash / Share |
-0.03 |
| Gross Margin |
15.78% |
| Operating Margin |
-232.00% |
| Profit Margin |
-350.90% |
| FCF Margin |
-57.66% |
| ROA |
-25.65% |
| ROE |
-102.59% |
| ROIC |
-227.60% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Low
7.00
Current: $0.2100
High
7.00
Target: 7.00
*Average 12-month price target from 1 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2020 | 2019 | 2018 |
|---|
| Revenue | 24.44 | 43.49 | 16.62 |
| Revenue Growth | -43.8% | 161.63% | - |
| Gross Profit | 3.86 | 27.20 | 12.65 |
| Operating Income | -56.70 | -19.94 | -12.33 |
| Net Income | -85.90 | -15.42 | -6.07 |
| Shares Outstanding | 290 | 266 | 241 |
| Earnings Per Share | -0.30 | -0.06 | -0.03 |
| Operating Cash Flow | -13.06 | 3.49 | -0.29 |
| Capital Expenditures | -1.03 | -2.71 | -1.76 |
| Free Cash Flow | -14.09 | 0.79 | -2.05 |
| Cash & Equivalents | 0.33 | 1.62 | 1.21 |
| Total Debt | 7.84 | 2.42 | - |
| Net Cash / Debt | -7.51 | -0.80 | 1.21 |
| Assets | 83.84 | 144 | 104 |
| Liabilities | 28.92 | 31.04 | 22.65 |
| Book Value | 55.29 | 113 | 81.46 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Predictive Technology Group, Inc. |
| Country |
United States |
| Employees |
62 |
| CEO |
Bradley C. Robinson |
Stock Information
| Ticker Symbol |
PRED |
| Stock Exchange |
US OTC |
| Sector |
Consumer Non-Durables |
| Industry |
Apparel/Footwear |
| Unique Identifier |
OTCMKTS: PRED |
Description
Predictive Technology Group, together with its subsidiaries, develops and commercializes discoveries and technologies involved in novel molecular diagnostic, therapeutic, and human cellular and tissue-based products (HCT/Ps). It operates in two segments, Human Cellular and Tissues Products (HCT/Ps); and Diagnostics and Therapeutics. The company provides FertilityDX, a genetic testing service for couples experiencing infertility; ARTguide, a genetic test for women experiencing infertility because of endometriosis and other genetic conditions; and regenerative medicine products, including AmnioCyte, AmnioCyte Plus, PolyCyte, and CoreCyte for use in regenerative medicine applications. It has a collaboration agreement with Atrin Pharmaceuticals LLC to develop molecular diagnostic tools to facilitate enhanced selection of cancer patients. The company was formerly known as Global Enterprises Group, Inc. and changed its name to Predictive Technology Group, Inc. in July 2015. Predictive Technology Group, Inc. was founded in 2005 and is headquartered in Salt Lake City, Utah.